Patrick Allihn is a dedicated research scientist specializing in mass spectrometry-based high-throughput proteomics to enhance early-stage drug discovery. Currently, at Evotec, Patrick supervises proteomics screening efforts focused on targeted protein degradation and implements novel high-throughput workflows. Previously, Patrick served as a postdoctoral research scientist at Technische Universität München, where they developed advanced chemoproteomic methods, and earned a PhD in Chemistry from the same institution. Patrick also holds a Master’s and Bachelor’s degree in Chemistry, with experience in various research internships throughout their academic career.
This person is not in the org chart
This person is not in any offices